CT vs IVUS-Guided PCI for Coronary Artery Disease

(P4 Trial)

This trial tests two methods to guide a procedure called PCI, which opens blocked heart arteries for those with coronary artery disease. One method uses a CT scan, a detailed imaging technique, while the other uses IVUS, an imaging tool inside the blood vessels. The trial aims to determine which method results in better patient outcomes. Individuals with stable heart conditions, such as angina or certain heart attacks, who require PCI may be suitable candidates for this trial. As an unphased study, it offers participants the chance to contribute to innovative research that could enhance future heart treatments.

The trial information does not specify if you need to stop taking your current medications. However, you must be able to take dual antiplatelet therapy (DAPT) for a certain period unless you are on chronic oral anticoagulation. It's best to discuss your specific medications with the trial team.

Research has shown that using CT scans to guide PCI (a heart procedure) is generally well-tolerated. One study found that coronary CT angiography (CCTA) aids doctors in planning and decision-making during the procedure. This method is considered safe, with few side effects reported.

In comparison, using ultrasound (IVUS) to guide PCI is a common practice recommended by the European Society of Cardiology. It is widely used because it provides clear images of the heart's blood vessels, and patients usually tolerate this procedure well.

Researchers are excited about the CT-guided PCI strategy for coronary artery disease because it offers a non-invasive approach to planning and guiding procedures. Unlike the standard IVUS-guided PCI, which involves inserting a device into the artery, the CT-guided method uses advanced software to analyze CT scans and assist doctors in visualizing and planning the intervention without direct vessel entry. This approach could potentially reduce procedural risks and make the treatment more comfortable for patients, while still providing detailed insights into the coronary arteries.

This trial will compare CT-guided PCI with IVUS-guided PCI for coronary artery disease. Research has shown that coronary CT angiography (CCTA), used in the CT-guided PCI arm of this trial, serves as a key tool for planning procedures to open blocked heart arteries, known as percutaneous coronary intervention (PCI). Studies indicate that CCTA can improve outcomes for patients suspected of having coronary artery disease by helping doctors plan more effective treatments. Specifically, trials have shown positive results when using CCTA for patients with acute coronary syndrome (ACS), highlighting its usefulness in guiding PCI. This technology provides detailed images of the heart's blood vessels, aiding in better treatment decisions. Overall, CCTA is increasingly recognized as a valuable method in planning PCI.³⁵⁶⁷